vs

Side-by-side financial comparison of Baxter International (BAX) and CONSTELLIUM SE (CSTM). Click either name above to swap in a different company.

Baxter International is the larger business by last-quarter revenue ($2.7B vs $2.2B, roughly 1.2× CONSTELLIUM SE). CONSTELLIUM SE runs the higher net margin — 5.1% vs -0.6%, a 5.6% gap on every dollar of revenue. CONSTELLIUM SE produced more free cash flow last quarter ($109.0M vs $76.0M).

Baxter International Inc. is an American multinational healthcare company with headquarters in Deerfield, Illinois.

Constellium SE is an American-Swiss, French-based global manufacturer of aluminium rolled products, extruded products, and structural parts based on a large variety of advanced alloys. Constellium's C-TEC research center has been credited for advancing technology in the field of advanced aluminium alloy. Constellium primarily serves the aerospace, automotive, and packaging sectors. Large clients include Mercedes-Benz, Audi, BMW, Fiat Chrysler Automotive, Ford, Airbus, Boeing, and Bombardier.

BAX vs CSTM — Head-to-Head

Bigger by revenue
BAX
BAX
1.2× larger
BAX
$2.7B
$2.2B
CSTM
Higher net margin
CSTM
CSTM
5.6% more per $
CSTM
5.1%
-0.6%
BAX
More free cash flow
CSTM
CSTM
$33.0M more FCF
CSTM
$109.0M
$76.0M
BAX

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
BAX
BAX
CSTM
CSTM
Revenue
$2.7B
$2.2B
Net Profit
$-15.0M
$112.0M
Gross Margin
33.0%
Operating Margin
2.4%
7.5%
Net Margin
-0.6%
5.1%
Revenue YoY
3.0%
Net Profit YoY
EPS (diluted)
$-0.03
$0.79

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BAX
BAX
CSTM
CSTM
Q1 26
$2.7B
Q4 25
$3.0B
$2.2B
Q3 25
$2.8B
$2.2B
Q2 25
$2.8B
$2.1B
Q1 25
$2.6B
$2.0B
Q4 24
$533.0M
Q3 24
$2.7B
Q2 24
$3.8B
$1.9B
Net Profit
BAX
BAX
CSTM
CSTM
Q1 26
$-15.0M
Q4 25
$-1.1B
$112.0M
Q3 25
$-46.0M
$88.0M
Q2 25
$91.0M
$36.0M
Q1 25
$126.0M
$37.0M
Q4 24
$-512.0M
Q3 24
$140.0M
Q2 24
$-314.0M
$76.0M
Gross Margin
BAX
BAX
CSTM
CSTM
Q1 26
33.0%
Q4 25
19.4%
Q3 25
33.5%
Q2 25
35.3%
Q1 25
32.8%
Q4 24
25.0%
Q3 24
38.3%
Q2 24
37.5%
Operating Margin
BAX
BAX
CSTM
CSTM
Q1 26
2.4%
Q4 25
-24.5%
7.5%
Q3 25
6.1%
5.8%
Q2 25
6.8%
2.7%
Q1 25
2.2%
3.1%
Q4 24
-25.5%
Q3 24
5.7%
Q2 24
-5.0%
5.4%
Net Margin
BAX
BAX
CSTM
CSTM
Q1 26
-0.6%
Q4 25
-37.9%
5.1%
Q3 25
-1.6%
4.1%
Q2 25
3.2%
1.7%
Q1 25
4.8%
1.9%
Q4 24
-96.1%
Q3 24
5.2%
Q2 24
-8.2%
3.9%
EPS (diluted)
BAX
BAX
CSTM
CSTM
Q1 26
$-0.03
Q4 25
$-2.21
$0.79
Q3 25
$-0.09
$0.62
Q2 25
$0.18
$0.25
Q1 25
$0.25
$0.26
Q4 24
$-0.99
Q3 24
$0.27
Q2 24
$-0.62
$0.51

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BAX
BAX
CSTM
CSTM
Cash + ST InvestmentsLiquidity on hand
$120.0M
Total DebtLower is stronger
$1.9B
Stockholders' EquityBook value
$952.0M
Total Assets
$5.4B
Debt / EquityLower = less leverage
2.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BAX
BAX
CSTM
CSTM
Q1 26
Q4 25
$2.0B
$120.0M
Q3 25
$1.7B
$122.0M
Q2 25
$1.7B
$133.0M
Q1 25
$2.3B
$118.0M
Q4 24
$1.8B
Q3 24
$1.4B
Q2 24
$2.1B
Total Debt
BAX
BAX
CSTM
CSTM
Q1 26
Q4 25
$9.5B
$1.9B
Q3 25
$2.0B
Q2 25
$2.0B
Q1 25
$1.9B
Q4 24
$10.4B
Q3 24
$10.4B
Q2 24
$10.4B
Stockholders' Equity
BAX
BAX
CSTM
CSTM
Q1 26
Q4 25
$6.1B
$952.0M
Q3 25
$7.2B
$845.0M
Q2 25
$7.3B
$780.0M
Q1 25
$7.1B
$745.0M
Q4 24
$7.0B
Q3 24
$7.9B
Q2 24
$7.6B
$796.0M
Total Assets
BAX
BAX
CSTM
CSTM
Q1 26
Q4 25
$20.1B
$5.4B
Q3 25
$21.1B
$5.4B
Q2 25
$21.0B
$5.4B
Q1 25
$21.3B
$5.2B
Q4 24
$25.8B
Q3 24
$26.7B
Q2 24
$26.3B
Debt / Equity
BAX
BAX
CSTM
CSTM
Q1 26
Q4 25
1.55×
2.00×
Q3 25
2.34×
Q2 25
2.53×
Q1 25
2.56×
Q4 24
1.49×
Q3 24
1.33×
Q2 24
1.37×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BAX
BAX
CSTM
CSTM
Operating Cash FlowLast quarter
$218.0M
Free Cash FlowOCF − Capex
$76.0M
$109.0M
FCF MarginFCF / Revenue
2.8%
5.0%
Capex IntensityCapex / Revenue
5.1%
5.0%
Cash ConversionOCF / Net Profit
1.95×
TTM Free Cash FlowTrailing 4 quarters
$159.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BAX
BAX
CSTM
CSTM
Q1 26
Q4 25
$584.0M
$218.0M
Q3 25
$237.0M
$99.0M
Q2 25
$217.0M
$114.0M
Q1 25
$-193.0M
$58.0M
Q4 24
$488.0M
Q3 24
$253.0M
Q2 24
$115.0M
$138.0M
Free Cash Flow
BAX
BAX
CSTM
CSTM
Q1 26
$76.0M
Q4 25
$109.0M
Q3 25
$24.0M
Q2 25
$37.0M
Q1 25
$-11.0M
Q4 24
Q3 24
Q2 24
$54.0M
FCF Margin
BAX
BAX
CSTM
CSTM
Q1 26
2.8%
Q4 25
5.0%
Q3 25
1.1%
Q2 25
1.8%
Q1 25
-0.6%
Q4 24
Q3 24
Q2 24
2.8%
Capex Intensity
BAX
BAX
CSTM
CSTM
Q1 26
5.1%
Q4 25
5.0%
Q3 25
3.5%
Q2 25
3.7%
Q1 25
3.5%
Q4 24
Q3 24
Q2 24
4.3%
Cash Conversion
BAX
BAX
CSTM
CSTM
Q1 26
Q4 25
1.95×
Q3 25
1.13×
Q2 25
2.38×
3.17×
Q1 25
-1.53×
1.57×
Q4 24
Q3 24
1.81×
Q2 24
1.82×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BAX
BAX

Segment breakdown not available.

CSTM
CSTM

Packaging Rolled Products$1.0B46%
Automotive Rolled Products$318.0M14%
Aerospace Rolled Products$270.0M12%
Transportation Industry Defense And Other Rolled Products$232.0M11%
Automotive Extruded Products$220.0M10%
Other Extruded Products$132.0M6%
Specialty And Other Thin Rolled Products$22.0M1%

Related Comparisons